Forbes -
24 Oct 2013 19:07
Analysts expect higher profit for Edwards Lifesciences when the company reports its third quarter results on Monday, October 28, 2013. The consensus estimate is calling for profit of 66 cents a share, reflecting a rise from 58 cents per share a year ago.
Share this Article
Comment on this Article
Please to comment